MyCarePulse + ASCENT for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if two tools, MyCarePulse and ASCENT, can help cancer patients overcome barriers to care, particularly in areas like food security and healthy eating habits. Researchers seek to understand whether patients using these tools feel more confident in their dietary choices and experience better diet quality compared to those receiving standard care. The trial is suitable for adults diagnosed with certain types of cancer, such as colorectal, prostate, or breast cancer, within the last year, who can read and speak English, and live in Florida. As an unphased trial, this study offers a unique opportunity to contribute to innovative research focused on improving cancer care and support.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the MyCarePulse and ASCENT patient navigator intervention is safe for cancer patients?
Research has shown that programs like the ASCENT Patient Navigator are generally easy for patients to handle. A review of studies found these programs helpful in cancer treatment, with few reports of negative effects. Past research has not linked MyCarePulse, another part of this trial, to major safety issues. Although this trial phase doesn't focus on safety, these programs aim to help patients manage their care rather than provide medical treatments, making them less likely to cause harm.12345
Why are researchers excited about this trial?
Researchers are excited about the MyCarePulse and ASCENT PN trial because it explores innovative ways to support cancer patients beyond standard medical treatments. Unlike typical cancer treatments that focus solely on medication or surgery, MyCarePulse is a digital tool that helps identify patients' needs, while ASCENT PN connects them to patient navigators for personalized support. This approach could enhance patient care by addressing emotional and logistical challenges, potentially leading to better overall outcomes and quality of life for cancer patients.
What evidence suggests that the MyCarePulse and ASCENT patient navigator intervention could be effective for cancer patients?
Research has shown that patient navigation can greatly assist cancer patients. About 70% of patients who received this support began their cancer treatments more smoothly. Patient navigation removes obstacles to care and organizes services, leading to better health outcomes. In this trial, participants will be divided into two groups: one group will receive the ASCENT Patient Navigator intervention alongside the MyCarePulse tool, while the other group will use MyCarePulse without the ASCENT intervention for comparison. The MyCarePulse and ASCENT program aims to improve access to healthy food and diet quality by offering personalized support. Overall, these efforts have shown promise in enhancing patient well-being and making care more accessible.12467
Are You a Good Fit for This Trial?
Adults over 18 with a recent diagnosis (within the past year) of specific cancers including colorectal, prostate, lung, breast, gynecologic, hematologic or skin cancer. Participants must speak English and be able to consent. Pregnant women and other vulnerable populations are excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Implementation Strategy
Participants complete the ASCENT Questionnaire, are assessed using the Veggie Meter, and participate in semi-structured interviews. Providers participate in interviews.
Phase 2: Intervention
Participants engage in ASCENT patient navigator screenings and consultations, complete the ASCENT Questionnaire, and utilize MyCarePulse.
Follow-up
Participants are monitored for changes in food security, diet quality, and self-efficacy for dietary behaviors.
What Are the Treatments Tested in This Trial?
Interventions
- MyCarePulse and ASCENT PN
Trial Overview
The trial is testing MyCarePulse and ASCENT patient navigator interventions against standard care in cancer patients. It aims to see if these can improve food security, self-efficacy for dietary behaviors, and diet quality through questionnaires and interviews.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be receiving the ASCENT Patient Navigator intervention, and the MyCarePulse tool will flag participants who need assistance. They will then be connected to an ASCENT Patient Navigator to get those needs assessed. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).
Participants not receiving the ASCENT Patient Navigator intervention, but are still utilizing MyCarePulse for comparison purposes. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
University of Miami
Collaborator
Citations
Study Details | NCT07042243 | The Florida ASCENT Study
Researchers will compare cancer patients receiving the MyCarePulse and ASCENT patient navigator intervention to those receiving standard care, to see if the ...
The Florida ASCENT Study
Purpose. The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers ...
Patient Navigation in Cancer Treatment: A Systematic Review
Amongst studies focused on cancer treatment initiation, 70% found a significant improvement in treatment initiation amongst patients who were enrolled in ...
Trials Today
... MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer. The main hypotheses it aims to test are: - At the patient ...
5.
oncologynurseadvisor.com
oncologynurseadvisor.com/reports/strengthening-oncology-patient-navigation-enhances-outcomes-treatment/Strengthening Oncology Patient Navigation Enhances ...
Patient navigation plays a critical role in reducing cancer disparities and improving outcomes by addressing barriers to care, coordinating services,
MyCarePulse and ASCENT PN in Melanoma and Cancer and ...
The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients ...
Trials Today
The study will be comprised of 3 patient cohorts: triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), and solid tumor types other than ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.